Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Jan;9(1):102–112. doi: 10.1128/aac.9.1.102

Susceptibility of Mycobacterium leprae to Dapsone as a Determinant of Patient Response to Acedapsone

Louis Levy *, John H Peters †
PMCID: PMC429483  PMID: 769667

Abstract

In the course of a clinical trial of acedapsone therapy in 17 patients with lepromatous leprosy, the rate of response to therapy was measured by inoculation of mice with Mycobacterium leprae recovered from biopsy specimens of skin lesions obtained before treatment and at intervals of 4, 12, and 24 weeks after institution of treatment. The susceptibility of each isolate of M. leprae to dapsone (4,4′-diaminodiphenylsulfone [DDS]) was measured by passaging organisms that had multiplied in mice to new groups of untreated mice and to mice treated with DDS incorporated in the mouse chow in concentrations of 10−5, 3 × 10−5, and 10−4 g/100 ml. The rate of response to acedapsone therapy and the susceptibility of patient strains of M. leprae to DDS varied widely among patients. All isolates were inhibited from multiplication by treatment of mice with 10−4 g of DDS per 100 ml; all but two isolates were susceptible to 3 × 10−5 g of DDS per 100 ml; and 17 of 36 isolates, representing nine patient strains, were susceptible to 10−5 g of DDS per 100 ml. Plasma levels of DDS measured in the mice administered these diets show that the minimal inhibitory concentration of DDS for M. leprae isolated from untreated patients is about 3 ng/ml. No relationship could be demonstrated between DDS susceptibility of pretreatment isolates of M. leprae and the rate at which patients responded to acedapsone therapy. Neither acedapsone treatment of patients nor DDS treatment of mice appeared to select genotypically more resistant M. leprae.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ellard G. A., Gammon P. T., Rees R. J., Waters M. F. Studies on the determination of the minimal inhibitory concentration of 4,4'-diamino-diphenyl-sulphone (Dapsone, DDS) against Mycobacterium leprae. Lepr Rev. 1971 Jun;42(2):101–117. doi: 10.5935/0305-7518.19710013. [DOI] [PubMed] [Google Scholar]
  2. Glazko A. J., Dill W. A., Montalbo R. G., Holmes E. L. A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men. Am J Trop Med Hyg. 1968 May;17(3):465–473. [PubMed] [Google Scholar]
  3. Levy L. Death of Mycobacterium leprae in mice, and the additional effect of dapsone administration. Proc Soc Exp Biol Med. 1970 Dec;135(3):745–749. doi: 10.3181/00379727-135-35134. [DOI] [PubMed] [Google Scholar]
  4. Levy L., Shepard C. C., Fasal P. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae. Am J Trop Med Hyg. 1972 May;21(3):315–321. doi: 10.4269/ajtmh.1972.21.315. [DOI] [PubMed] [Google Scholar]
  5. Murray J. F., Jr, Gordon G. R., Gulledge C. C., Peters J. H. Chromatographic-fluorometric analysis of antileprotic sulfones. J Chromatogr. 1975 Apr 9;107(1):67–72. doi: 10.1016/s0021-9673(00)82748-x. [DOI] [PubMed] [Google Scholar]
  6. Murray J. F., Jr, Gordon G. R., Peters J. H. A chromatographic-fluorometric procedure for the determination of nanogram quantities of antileprotic sulfones. J Lab Clin Med. 1971 Sep;78(3):464–471. [PubMed] [Google Scholar]
  7. Ozawa T., Shepard C. C., Karat A. B. Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD). Am J Trop Med Hyg. 1971 Mar;20(2):274–281. doi: 10.4269/ajtmh.1971.20.274. [DOI] [PubMed] [Google Scholar]
  8. Peters J. H., Lin S. C., Levy L. A rapid qualitative spot test for the detection of dapsone in urine. Int J Lepr Other Mycobact Dis. 1969 Jan-Mar;37(1):46–51. [PubMed] [Google Scholar]
  9. Shepard C. C. A survey of the drugs with activity against M. leprae in mice. Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):340–348. [PubMed] [Google Scholar]
  10. Shepard C. C. Activity of repository sulfones against Mycobacterium leprae in mice. Proc Soc Exp Biol Med. 1967 Feb;124(2):430–433. doi: 10.3181/00379727-124-31757. [DOI] [PubMed] [Google Scholar]
  11. Shepard C. C. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392. Int J Lepr Other Mycobact Dis. 1969 Oct-Dec;37(4):389–397. [PubMed] [Google Scholar]
  12. Shepard C. C., Levy L., Fasal P. Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae. Am J Trop Med Hyg. 1974 Nov;23(6):1120–1124. doi: 10.4269/ajtmh.1974.23.1120. [DOI] [PubMed] [Google Scholar]
  13. Shepard C. C., Levy L., Fasal P. Rapid bactericidal effect of rifampin on Mycobacterium leprae. Am J Trop Med Hyg. 1972 Jul;21(4):446–449. doi: 10.4269/ajtmh.1972.21.446. [DOI] [PubMed] [Google Scholar]
  14. Shepard C. C., Levy L., Fasal P. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients. Am J Trop Med Hyg. 1968 Sep;17(5):769–775. doi: 10.4269/ajtmh.1968.17.769. [DOI] [PubMed] [Google Scholar]
  15. Shepard C. C., Levy L., Fasal P. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS). Am J Trop Med Hyg. 1972 Jul;21(4):440–445. doi: 10.4269/ajtmh.1972.21.440. [DOI] [PubMed] [Google Scholar]
  16. Shepard C. C., Levy L., Fasal P. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Am J Trop Med Hyg. 1969 Mar;18(2):258–263. [PubMed] [Google Scholar]
  17. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]
  18. Shepard C. C., Tolentino J. G., McRae D. H. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy. Am J Trop Med Hyg. 1968 Mar;17(2):192–201. doi: 10.4269/ajtmh.1968.17.192. [DOI] [PubMed] [Google Scholar]
  19. THOMPSON P. E., OLSZEWSKI B., WAITZ J. A. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501). Am J Trop Med Hyg. 1965 May;14:343–353. doi: 10.4269/ajtmh.1965.14.343. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES